Seattle, WA, July 27, 2017 --
Jones Soda Co. (OTCQB: JSDA), a leader in the premium soda category and known for its unique branding and innovative marketing, today announced that it will host a conference call to discuss financial results for its second quarter on Thursday, August 3rd, 2017 at 4:30 p.m. Eastern Time. Jones Soda will announce its financial results for this period in a press release after the market close on August 3rd, 2017.
This call will be webcast and can be accessed by visiting the Investor section of the Company’s website at www.jonessoda.com. Investors may also listen to the call via telephone by dialing (719) 785-9448 (conference ID: 1965708). In addition, a telephone replay will be available by dialing (412) 317-6671 (conference ID: 1965708) through August 10th, 2017, at 11:59 p.m. Eastern Time.
About Jones Soda Co
Headquartered in Seattle, Washington, Jones Soda Co.® (OTCQB: JSDA) markets and distributes premium beverages under the Jones® Soda, Jones Zilch®, Jones Stripped™ and Lemoncocco® brands. A leader in the premium soda category, Jones Soda is known for its variety of flavors, made with cane sugar and other high quality ingredients and incorporating always-changing photos sent in from its consumers. The diverse product line of Jones offers something for everyone – pure cane sugar soda, zero-calorie soda and an all-naturally sweetened sparkling beverage with only 30 calories and Lemoncocco® non-carbonated premium refreshment. Jones Soda is sold across North America in glass bottles, cans and on fountain through traditional beverage outlets, restaurants and alternative accounts. For more information, visit www.jonessoda.com or www.myjones.com or www.drinklemoncocco.com.
Max Schroedl Chief Financial Officer Jones Soda Co. (206) 624-3357 or [email protected]


Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing 



